DEERFIELD MANAGEMENT COMPANY, L.P.
New York, NY · CIK 1009258 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2012 · limited partnership
- Assets managed$19.1bn
- Staff189 · 89 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (11 hedge) · $19.2bn gross assets
- Form ADV · 2026-07-31SEC adviser record
- Legal entityDEERFIELD MANAGEMENT COMPANY, L.P. (US)
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY, Parsippany, NJ
As an employer
- Offices in1 country
- Private fundshedge 11, private equity 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 86 |
| Parsippany, NJUnited States | 3 |
US visa salary filings
- Filings FY2024–20266
- Median salary offered$160,000
- Middle half$140,000 – $191,250
- Job titles5
| Job title | Filings | Median |
|---|---|---|
| AnalystNew York, NY | 2 | $140,000 |
| Data EngineerNew York, NY | 1 | $210,000 |
| Senior Director, Business IntelligenceNew York, NY | 1 | $195,000 |
| Director, Business IntelligenceNew York, NY | 1 | $180,000 |
| Market Research AssociateNew York, NY | 1 | $80,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Flynn Management LLC – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NUVALENT INC COM | $1.4bn24.91% | Unchanged |
| OSCAR HEALTH INC OSCR | $249.8m4.53% | Reduced -191.2k |
| VIATRIS INC VTRS | $214.5m3.89% | Added +32.3k |
| MERUS N V MRUS | $178.0m3.23% | Added +210.7k |
| CENTENE CORP DEL CNC | $172.9m3.14% | Added +513.4k |
| INTEGRA LIFESCIENCES HLDGS C IART 0.5 08.15.25 · principal | $172.9m3.14% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $169.7m3.08% | Reduced -790.1k |
| INDIVIOR PLC INDV | $155.8m2.83% | Unchanged |
| UNITED THERAPEUTICS CORP DEL UTHR | $155.3m2.82% | Added +265.4k |
| NEUROCRINE BIOSCIENCES INC NBIX | $146.8m2.66% | Reduced -321.2k |
| ALNYLAM PHARMACEUTICALS INC ALNY 1 09.15.27 · principal | $143.2m2.60% | Unchanged |
| REVOLUTION MEDICINES INC RVMD | $124.5m2.26% | Added +66.7k |
| MIRUM PHARMACEUTICALS INC MIRM 4 05.01.29 · principal | $124.2m2.25% | Unchanged |
| BROOKDALE SR LIVING INC BKD | $106.9m1.94% | Reduced -250.0k |
| LEGEND BIOTECH CORP LEGN | $105.1m1.91% | Added +1.2m |
| PFIZER INC PFE | $104.4m1.89% | Added +959.0k |
| ADAPTHEALTH CORP AHCO | $93.4m1.70% | Added +193.5k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $92.6m1.68% | Added +1.0m |
| IDEAYA BIOSCIENCES INC IDYA | $82.3m1.49% | Added +647.8k |
| VERA THERAPEUTICS INC VERA | $78.9m1.43% | Added +2.3m |
| INSMED INC INSM | $70.5m1.28% | Added +242.7k |
| MERCK & CO INC MRK | $67.9m1.23% | New |
| CATALYST PHARMACEUTICALS INC CPRX | $62.5m1.13% | Reduced -542.7k |
| LARIMAR THERAPEUTICS INC LRMR | $61.4m1.11% | Unchanged |
| BAXTER INTL INC BAX | $58.2m1.06% | Unchanged |
| BIO RAD LABS INC BIO | $54.6m0.99% | Unchanged |
| DISC MEDICINE INC IRON | $48.7m0.88% | Added +137.1k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $47.3m0.86% | Unchanged |
| ENHABIT INC EHAB | $46.1m0.84% | Reduced -217.9k |
| CERTARA INC CERT | $45.9m0.83% | Added +1.9m |
| ENVISTA HOLDINGS CORPORATION NVST | $43.3m0.79% | Added +190.9k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $42.0m0.76% | Reduced -497.7k |
| TANDEM DIABETES CARE INC TNDM 1.5 03.15.29 2024 · principal | $38.5m0.70% | New |
| CONMED CORP CNMD | $36.5m0.66% | Added +89.3k |
| PHARVARIS N V PHVS | $35.5m0.64% | Unchanged |
| LANTHEUS HLDGS INC LNTH 2.625 12.15.27 · principal | $32.1m0.58% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $29.0m0.53% | Reduced -5.3k |
| PRAXIS PRECISION MEDICINES I PRAX | $28.9m0.52% | Added +67.0k |
| PHREESIA INC PHR | $28.9m0.52% | Added +4.7k |
| KYMERA THERAPEUTICS INC KYMR | $28.5m0.52% | Added +60.0k |
| MODERNA INC MRNA | $27.6m0.50% | New |
| EDGEWISE THERAPEUTICS INC EWTX | $27.1m0.49% | Reduced -11.2k |
| EMBECTA CORP EMBC | $26.6m0.48% | Added +29.2k |
| IMMUNOCORE HLDGS PLC IMCR 2.5 02.01.30 · principal | $25.8m0.47% | Unchanged |
| LIVANOVA PLC LIVN 2.5 03.15.29 · principal | $25.4m0.46% | New |
| DAY ONE BIOPHARMACEUTICALS I COM | $24.2m0.44% | Added +762.4k |
| VENTAS INC VTR | $22.4m0.41% | New |
| LIQUIDIA CORPORATION LQDA | $20.1m0.37% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $19.0m0.34% | Added +6.4k |
| MEREO BIOPHARMA GROUP PLC MREO | $18.2m0.33% | Unchanged |
| INSPIRE MED SYS INC INSP | $18.2m0.33% | New |
| SAVARA INC SVRA | $18.2m0.33% | Unchanged |
| XERIS BIOPHARMA HOLDINGS INC XERS 8 07.15.28 · principal | $17.7m0.32% | Unchanged |
| BETA BIONICS INC BBNX | $17.0m0.31% | Added +152.4k |
| XENON PHARMACEUTICALS INC XENE | $17.0m0.31% | New |
| VERACYTE INC VCYT | $16.9m0.31% | New |
| SIONNA THERAPEUTICS INC SION | $16.8m0.31% | Added +223.6k |
| NEOGENOMICS INC NEO | $15.7m0.28% | New |
| FOGHORN THERAPEUTICS INC FHTX | $15.3m0.28% | Unchanged |
| ZENAS BIOPHARMA INC ZBIO | $15.1m0.27% | Unchanged |
| NOVOCURE LTD NVCR | $14.7m0.27% | Added +175.0k |
| TAYSHA GENE THERAPIES INC TSHA | $12.4m0.23% | New |
| RXSIGHT INC RXST | $11.6m0.21% | Added +496.6k |
| DELCATH SYS INC DCTH | $11.1m0.20% | Reduced -545 |
| OMADA HEALTH INC OMDA | $10.1m0.18% | New |
| INTEGRA LIFESCIENCES HLDGS C IART | $9.8m0.18% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $9.2m0.17% | Added +163.7k |
| DOCGO INC DCGO | $7.8m0.14% | Reduced -109.9k |
| STRUCTURE THERAPEUTICS INC GPCR | $7.7m0.14% | Unchanged |
| VAXCYTE INC PCVX | $7.3m0.13% | Unchanged |
| THE ONCOLOGY INSTITUTE INC STLN | $6.9m0.13% | Unchanged |
| SIMULATIONS PLUS INC COM | $6.2m0.11% | Unchanged |
| NEUROPACE INC NPCE | $5.6m0.10% | Unchanged |
| JADE BIOSCIENCES INC JBIO | $5.3m0.10% | New |
| PULMONX CORP LUNG | $4.9m0.09% | Unchanged |
| ALIGNMENT HEALTHCARE INC ALHC | $4.8m0.09% | Reduced -4.2m |
| HILLEVAX INC COM | $3.7m0.07% | Unchanged |
| CALCIMEDICA INC COM NEW | $2.1m0.04% | Unchanged |
| ALECTOR INC ALEC | $1.5m0.03% | Unchanged |
| ANNEXON INC ANNX | $1.4m0.03% | Unchanged |
| BIOMX INC COM NEW | $1.1m0.02% | Unchanged |
| TWIST BIOSCIENCE CORP TWST | $876.6k0.02% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $742.3k0.01% | Unchanged |
| SOTERA HEALTH CO SHC | $503.1k0.01% | New |
| COOPER COS INC COO | $450.3k0.01% | New |
| THERMO FISHER SCIENTIFIC INC TMO | $371.4k0.01% | New |
| UFP TECHNOLOGIES INC UFPT | $370.4k0.01% | New |
| ALIGN TECHNOLOGY INC ALGN | $368.2k0.01% | New |
| ATRICURE INC ATRC | $365.0k0.01% | New |
| LEMAITRE VASCULAR INC LMAT | $346.2k0.01% | New |
| ORTHOPEDIATRICS CORP KIDS | $332.6k0.01% | New |
| ENOVIS CORPORATION ENOV | $322.0k0.01% | New |
| NATIONAL HEALTHCARE CORP NHC | $313.1k0.01% | New |
| DAVITA INC DVA | $299.3k0.01% | New |
| BIOLIFE SOLUTIONS INC BLFS | $294.5k0.01% | New |
| UNIVERSAL HLTH SVCS INC UHS | $289.3k0.01% | New |
| AMEDISYS INC AMED | $270.0k0.00% | New |
| HAEMONETICS CORP MASS HAE | $263.3k0.00% | New |
| IQVIA HLDGS INC IQV | $255.8k0.00% | New |
| MIMEDX GROUP INC MDXG | $240.4k0.00% | New |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| ACCOLADE INC ACCD 0.5 04.01.26 | $130.6m132.6m shares |
| DYNAVAX TECHNOLOGIES CORP DVAX | $67.3m5.2m shares |
| CHIMERIX INC CMRX | $32.1m3.8m shares |
| INMODE LTD INMD | $28.0m1.6m shares |
| LANTHEUS HLDGS INC LNTH | $23.4m240.2k shares |
| CG ONCOLOGY INC CGON | $20.8m850.7k shares |
| BEAM THERAPEUTICS INC BEAM | $17.1m877.8k shares |
| CONCENTRA GROUP HOLDINGS PAR CON | $14.1m650.0k shares |
| METSERA INC | $13.6m500.0k shares |
| OPKO HEALTH INC OPK | $11.5m6.9m shares |
| GH RESEARCH PLC GHRS | $10.2m925.0k shares |
| DYNE THERAPEUTICS INC DYN | $8.5m812.4k shares |
| PERSPECTIVE THERAPEUTICS INC CATX | $6.0m2.8m shares |
| NEUROGENE INC NGNE | $5.2m446.9k shares |
| ST JOE CO JOE | $210.0k4.5k shares |
| DXC TECHNOLOGY CO DXC | $202.6k11.9k shares |
| XPONENTIAL FITNESS INC XPOF | $192.4k23.1k shares |
| FARMLAND PARTNERS INC FPI | $188.0k16.9k shares |
| HALLADOR ENERGY COMPANY HNRG | $168.4k13.7k shares |
| RING ENERGY INC REI | $146.5k127.4k shares |
| MFA FINL INC MFA | $112.2k10.9k shares |
| PETCO HEALTH & WELLNESS CO I WOOF | $108.1k35.4k shares |
| BACKBLAZE INC BLZE | $103.7k21.5k shares |
| VIR BIOTECHNOLOGY INC VIR | $101.9k15.7k shares |
| MEDIAALPHA INC MAX | $99.7k10.8k shares |
Trades reported as a company insider in Q2 2025
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2025-06-27 | ARS PHARMACEUTICALS INC 10% owner · Through Deerfield Private Design Fund III, L.P. | Sold | $6.8m370.1k shares |
| 2025-06-27 | ARS PHARMACEUTICALS INC 10% owner · Through Deerfield Private Design Fund IV, L.P. | Sold | $6.8m370.1k shares |